Back to top

Image: Bigstock

Here's What Key Metrics Tell Us About Trustmark (TRMK) Q2 Earnings

Read MoreHide Full Article

For the quarter ended June 2024, Trustmark (TRMK - Free Report) reported revenue of $185.84 million, down 5.6% over the same period last year. EPS came in at $0.66, compared to $0.74 in the year-ago quarter.

The reported revenue represents a surprise of -19.14% over the Zacks Consensus Estimate of $229.83 million. With the consensus EPS estimate being $0.61, the EPS surprise was +8.20%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Trustmark performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Net (recoveries) charge-offs / average loans: 0.1% versus the three-analyst average estimate of 0.2%.
  • Average Balances - Total earning assets: $17.19 billion versus $17.04 billion estimated by three analysts on average.
  • Net Interest Margin: 2.3% versus 3.3% estimated by three analysts on average.
  • Efficiency Ratio: 63.8% compared to the 70.1% average estimate based on two analysts.
  • Total nonaccrual LHFI: $44.29 million versus the two-analyst average estimate of $98.57 million.
  • Net Interest Income: $141.03 million compared to the $134.45 million average estimate based on three analysts.
  • Net Interest Income (FTE): $144.33 million compared to the $137.87 million average estimate based on three analysts.
View all Key Company Metrics for Trustmark here>>>

Shares of Trustmark have returned +17.8% over the past month versus the Zacks S&P 500 composite's +2% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.

See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Trustmark Corporation (TRMK) - free report >>

Published in